In clear cell renal cell carcinoma, transcription factor NFYA was reported to be able to simultaneous transactivating CCND1 and CDK4 to promote G1/S cycle transition thus accelerating tumor development and predicting poor prognosis [25]. This evidence concerns the gene NFYA and neoplasm.